NCT05400382 · University of Illinois at Urbana-Champaign
Maternal Mindfulness: Depression and Postpartum Pain
(MaMiDaPP)
What this study is about
This phase I clinical trial tests the feasibility and safety of a self-guided, mobile mindfulness-based intervention to reduce post-cesarean pain and prevent postpartum depression.
View original scientific description
This phase I clinical trial tests the feasibility and safety of a self-guided, mobile mindfulness-based intervention to reduce post-cesarean pain and prevent postpartum depression.
Interventions
BEHAVIORAL
Mindfulness
Meditation training to help reduce stress and reactivity to pain and other stressors.
Primary outcome measures
Post-operative pain
Time frame: 1 week postpartum and 8 weeks postpartum
Numerical Pain Rating Scale (NPRS); Participant reported pain intensity (0 is equivalent to no pain and 10 indicates the worst possible pain) and pain unpleasantness (0 is equivalent to not at all unpleasant and 10 indicates the most unpleasant feeling possible)
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Women must self-identify as Latina/Latinx/Hispanic, Asian, African American, or non-Hispanic White.
- Scheduled to undergo a planned cesarean delivery.
- Be of 18-45 years of age
- Have a singleton pregnancy
- Score between 5 and 13 on the Edinburgh Postnatal Depression Scale (EPDS)
- A history of depression
- Have no chronic pain condition (e.g., fibromyalgia)
- Own a computer, smartphone, or tablet
- Have a reliable internet access to complete the online surveys.
- Be proficient in English or Spanish.
Where
- Champaign, Illinois
Collaborators
Southern Illinois University, Arrowhead Regional Medical Center, University of Utah
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Aug 6, 2026 · Source of record for eligibility and locations